IFNG and infection: Consistent with reduced morbidity and mortality in the EBOV GP/rVSV infected, IFNγ-treated mice, mice treated with 3.3 μg of IFNγ at 24 hour before infection had dramatically lower EBOV GP/rVSV viremia at day 2 of infection (Fig 5B).